Literature DB >> 9599656

Fibroblast growth factors and their receptors.

Z Galzie1, A R Kinsella, J A Smith.   

Abstract

Fibroblast growth factors (FGFs) represent a group of polypeptide mitogens eliciting a wide variety of responses depending upon the target cell type. The knowledge of the cell surface receptors mediating the effects of FGFs has recently expanded remarkably. The complexity of the FGF family and the FGF-induced responses is reflected in the diversity and redundancy of the FGF receptors. In this review, a number of biochemical characteristics and biological properties of the FGF family and its receptors are described and their expression both in normal tissues and in tumours is discussed. Finally we speculate on the targetting of growth inhibition agents to tumours through FGF receptors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9599656

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  27 in total

Review 1.  Clinical applications of vascular gene therapy.

Authors:  J Rutanen; T T Rissanen; A Kivelä; I Vajanto; S Ylä-Herttuala
Journal:  Curr Cardiol Rep       Date:  2001-01       Impact factor: 2.931

Review 2.  Cardiac cell therapy: boosting mesenchymal stem cells effects.

Authors:  E Samper; A Diez-Juan; J A Montero; P Sepúlveda
Journal:  Stem Cell Rev Rep       Date:  2013-06       Impact factor: 5.739

Review 3.  Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin?

Authors:  Mariabeatrice Principi; Floriana Giorgio; Giuseppe Losurdo; Viviana Neve; Antonella Contaldo; Alfredo Di Leo; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2013-11-15

4.  Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice.

Authors:  D L Miller; S Ortega; O Bashayan; R Basch; C Basilico
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Specific capture of mammalian cells by cell surface receptor binding to ligand immobilized on gold thin films.

Authors:  Dora Peelen; Voula Kodoyianni; Jieun Lee; Ting Zheng; Michael R Shortreed; Lloyd M Smith
Journal:  J Proteome Res       Date:  2006-07       Impact factor: 4.466

6.  FGF-21 as a novel metabolic regulator.

Authors:  Alexei Kharitonenkov; Tatiyana L Shiyanova; Anja Koester; Amy M Ford; Radmila Micanovic; Elizabeth J Galbreath; George E Sandusky; Lisa J Hammond; Julie S Moyers; Rebecca A Owens; Jesper Gromada; Joseph T Brozinick; Eric D Hawkins; Victor J Wroblewski; De-Shan Li; Farrokh Mehrbod; S Richard Jaskunas; Armen B Shanafelt
Journal:  J Clin Invest       Date:  2005-05-02       Impact factor: 14.808

7.  A heparin-mimicking reverse thermal gel for controlled delivery of positively charged proteins.

Authors:  Brisa Peña; Robin Shandas; Daewon Park
Journal:  J Biomed Mater Res A       Date:  2014-10-21       Impact factor: 4.396

8.  FGFR4 genetic polymorphisms determine the chemotherapy response of Chinese patients with non-small cell lung cancer.

Authors:  Hong-mei Fang; Gang Tian; Li-juan Zhou; Han-ying Zhou; Ying-zhi Fang
Journal:  Acta Pharmacol Sin       Date:  2013-03-25       Impact factor: 6.150

9.  Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain.

Authors:  Ian E McCutcheon; Stephen J Hentschel; Gregory N Fuller; Wei Jin; Gilbert J Cote
Journal:  Neuro Oncol       Date:  2004-01       Impact factor: 12.300

10.  FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities.

Authors:  S Allerstorfer; G Sonvilla; H Fischer; S Spiegl-Kreinecker; C Gauglhofer; U Setinek; T Czech; C Marosi; J Buchroithner; J Pichler; R Silye; T Mohr; K Holzmann; B Grasl-Kraupp; B Marian; M Grusch; J Fischer; M Micksche; W Berger
Journal:  Oncogene       Date:  2008-03-24       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.